Skip to main content

Pharmaceutical and chemical companies questioned on facilitating UK-EU trade

19 June 2020

The EU Goods Sub-Committee hears evidence from the businesses in the pharmaceuticals and chemicals sectors on how to facilitate UK-EU trade beyond tariffs.



Monday 22 June 2020 at 10.30am , virtual meeting

the Committee will hear from:

  • Dr Louise Gill, Head of Policy, Global Regulatory Affairs, GlaxoSmithKline
  • Richard Ayton, Director of Government Affairs, Dow Chemical UK and Ireland

Areas of interest 

 Possible questions that may be asked by the Committee include:

  • What regulatory provisions would you like to see in the UK-EU trade agreement?
  • How important is the mutual recognition of good manufacturing practices / conformity assessments?
  • What form should UK-EU cooperation on market surveillance take?
  • How will new UK-EU customs procedures at the end of the transition period impact your businesses?
  • Do you have any specific concerns?
  • Are there any unilateral measures that the UK could take to reduce non-tariff barriers to UK-EU trade?

Further information